Skip to main content

Advertisement

SpringerLink
Log in

Impact of Distal Pancreatectomy on Outcomes of Peritoneal Surface Disease Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  • Regional Cancer Therapies
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Left upper quadrant involvement by peritoneal surface disease (PSD) may require distal pancreatectomy (DP) to obtain complete cytoreduction. Herein, we study the impact of DP on outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).

Methods

Analysis of a prospective database of 1,019 procedures was performed. Malignancy type, performance status, resection status, comorbidities, Clavien-graded morbidity, mortality, and overall survival were reviewed.

Results

DP was a component of 63 CRS/HIPEC procedures, of which 63.3 % had an appendiceal primary. While 30-day mortality between patients with and without DP was no different (2.6 vs. 3.2 %; p = 0.790), 30-day major morbidity was worse in patients receiving a DP (30.2 vs. 18.8 %; p = 0.031). Pancreatic leak rate was 20.6 %. Intensive care unit days and length of stay were longer in DP versus non-DP patients (4.6 vs. 3.5 days, p = 0.007; and 22 vs. 14 days, p < 0.001, respectively). Thirty-day readmission was similar for patients with and without DP (29.2 vs. 21.1 %; p = 0.205). Median survival for low-grade appendiceal cancer (LGA) patients requiring DP was 106.9 months versus 84.3 months when DP was not required (p = 0.864). All seven LGA patients undergoing complete cytoreduction inclusive of DP were alive at the conclusion of the study (median follow-up 11.8 years).

Conclusions

CRS/HIPEC including DP is associated with a significant increase in postoperative morbidity but not mortality. Survival was similar for patients with LGA whether or not DP was performed. Thus, the need for a DP should not be considered a contraindication for CRS/HIPEC procedures in LGA patients when complete cytoreduction can be achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449–56.

    Article  PubMed  Google Scholar 

  2. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63–8.

    Article  PubMed  Google Scholar 

  3. Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116:5608–18.

    Article  PubMed  Google Scholar 

  4. Shen P, Stewart JH, Levine EA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale. Curr Probl Cancer. 2009;33:125–41.

    Article  PubMed  Google Scholar 

  5. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.

    Article  PubMed  Google Scholar 

  7. Goere D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065–71.

    Article  PubMed  Google Scholar 

  8. Chi DS, Zivanovic O, Levinson KL, et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010;119:38–42.

    Article  PubMed  Google Scholar 

  9. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer. Gynecol Oncol. 2006;103:1083–90.

    Article  PubMed  Google Scholar 

  10. Hoffman MS, Tebes SJ, Sayer RA, et al. Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection. Am J Obstet Gynecol. 2007;197:209–14.

    Article  Google Scholar 

  11. Zhou W, Lv R, Wang X, et al. Stapler vs suture closure of pancreatic remnant after distal pancreatectomy: a meta-analysis. Am J Surg. 2010;200:529–36.

    Article  PubMed  Google Scholar 

  12. Harris LJ, Abdollahi H, Newhook T, Sauter PK, Crawford AG, Chojnacki KA, et al. Optimal technical management of stump closure following distal pancreatectomy: a retrospective review of 215 cases. J Gastrointest Surg. 2010;14(6):998–1005.

    Article  PubMed  Google Scholar 

  13. Diener MK, Seiler CM, Rossion I, Kleeff J, Glanemann M, Butturini G, et al. Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet. 2011;377(9776):1514–22.

    Article  PubMed  Google Scholar 

  14. Johnston FM, Cavataio A, Strasberg SM, Hamilton NA, Simon PO, Trinkaus K, et al. The effect of mesh reinforcement of a stapled transection line on the rate of pancreatic occlusion failure after distal pancreatectomy: review of a single institution’s experience. HPB (Oxford). 2009;11(1):25–31.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Hamilton NA, Porembka MR, Johnston FM, et al. Mesh reinforcement of pancreatic transection decreases incidence of pancreatic occlusion failure for left pancreatectomy: a single-blinded, randomized controlled trial. Ann Surg. 2012;255:1037–42.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Jin T, Altaf K, Xiong JJ, et al. A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB (Oxford). 2012;14:711–24.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kleeff J, Diener MK, Z’graggen K, et al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg. 2007;245:573–82.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Venkat R, Edil BH, Schulick RD, et al. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012;255:1048-1059.

    Article  PubMed  Google Scholar 

  19. Jimenez RE, Hawkins WG. Emerging strategies to prevent the development of pancreatic fistula after distal pancreatectomy. Surgery. 2012;152(3 Suppl 1):S64–70.

    Article  PubMed  Google Scholar 

  20. Fahy BN, Frey CF, Ho HS, Beckett L, Bold RJ. Morbidity, mortality and technical factors of distal pancreatectomy. Am J Surg. 2002;183(3):237–41.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Wake Forest University Biostatistics shared resource NCI CCSG P30CA012197.

Disclosures

None.

Author information

Authors and Affiliations

  1. Surgical Oncology Service, Department of General Surgery, Wake Forest University, Winston-Salem, NC, USA

    Andrea N. Doud MD, Reese W. Randle MD, Clancy J. Clark MD, Edward A. Levine MD, Perry Shen MD, John H. Stewart MD & Konstantinos I. Votanopoulos MD, PhD, FACS

  2. Department of Biostatistics, Wake Forest University, Winston-Salem, NC, USA

    Katrina R. Swett MS

Authors
  1. Andrea N. Doud MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reese W. Randle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Clancy J. Clark MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Edward A. Levine MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katrina R. Swett MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Perry Shen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John H. Stewart MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Konstantinos I. Votanopoulos MD, PhD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Konstantinos I. Votanopoulos MD, PhD, FACS.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doud, A.N., Randle, R.W., Clark, C.J. et al. Impact of Distal Pancreatectomy on Outcomes of Peritoneal Surface Disease Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 22, 1645–1650 (2015). https://doi.org/10.1245/s10434-014-3976-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-3976-z

Keywords

Search

Navigation